ロード中...
Inhibition of the covalent binding reaction of complement component C4 by penicillamine, an anti-rheumatic agent.
D(-)-Penicillamine [D(-)-beta beta-dimethylcysteine] is an anti-arthritic drug, but its use is limited by adverse side effects, which include problems in immune-complex clearance. Complement is important as a source of inflammatory mediators in rheumatoid arthritis and is also involved in immune-com...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1989
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1138525/ https://ncbi.nlm.nih.gov/pubmed/2785792 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|